The origins of concentric demyelination: Self-organization in the human brain

PLoS ONE

Volumn 2, Issue 1, 2007, Pages

  Khonsari, Roman H ^a,b   Calvez, Vincent ^c  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c ECOLE NORMALE SUPÉRIEURE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BALO CONCENTRIC SCLEROSIS; CELL ACTIVITY; CHEMOTAXIS; DEMYELINATION; DISEASE COURSE; HUMAN; IMMUNOPATHOLOGY; MATHEMATICAL MODEL; MOLECULAR DYNAMICS; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; PATHOGENESIS; BRAIN; DEMYELINATING DISEASE; HISTOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCHILDER DISEASE; THEORETICAL MODEL;

BRAIN; CHEMOTAXIS; DEMYELINATING DISEASES; DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; HUMANS; MODELS, THEORETICAL;

EID: 34250185550     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000150     Document Type: Article

References (47)

1. Baló J (1927) Leucoencephalitis periaxialis concentrica. Magy Orvosi Arch 28: 108-124.
2. Hallervorden J, Spatz H (1933) Über die konzentrische Sklerose und die physicalisch-chemischen Faktoren bei der Ausbreitung von Entmarkungsprozessen. Arch Psychiat Nervenkr 98: 641-701.
3. Lumsden CE (1970) The neuropathology of multiple sclerosis. In: Vinken PJ, Bruyn GW, eds. Handbook of clinical neurology, vol. 9. Amsterdam: North Holland Publishing Co. pp. 217-319.
4. Stadelmann C, Brück W (2004) Lessons from the neuropathology of atypical forms of multiple sclerosis. Neurol Sci 25: S319-S322.
5. Chen CJ, Chu NS, Lu CS, Sung CY (1999) Serial magnetic resonance imaging in patients with Baló's concentric sclerosis: natural history of lesion development. Ann Neurol 46: 651-656.
6. Kastrup O, Stude P, Limmroth V (2002) Baló's concentric sclerosis - evolution of active demyelination demonstrated by serial contrast-enhanced MRI. J Neurol 249: 811-814.
7. Chen CJ (2001) Serial proton magnetic resonance spectroscopy in lesions of Baló concentric sclerosis. J Comput Assist Tomogr 25: 713-718.
8. Lassmann H (2005) Multiple sclerosis pathology: evolution of pathogenic concepts. Brain Pathol 15: 217-222.
9. Yao DL, Webster HD, Hudson LD, Brenner M, Liu DS, et al. (1994) Concentric sclerosis (Baló): morphometric and in situ hybridization study of lesions in six patients. Ann Neurol 35: 18-30.
10. Aboul-Enein F, Lassmann H (2005) Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol 109: 49-55.
11. Barnett MH, Prineas JW (2004) Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 55: 458-468.
12. Courville CB (1970) Concentric sclerosis. In: Vinken PJ, Bruyn GW, eds. Multiple sclerosis and other demyelinating diseases. Amsterdam: North-Holland. pp. 437-451.
13. Ferraro A (1933) Experimental toxic encephalopathy. Diffuse sclerosis following subcutaneous injection of potassium-cyanide. Psychiat Q 7: 267-283.
14. Markiewicz D, Adamczewska-Goncerzewicz Z, Dymecki J, Goncerzewicz A (1977) A case of primary form of progressive multifocal leukoencephalopathy with concentric demyelination of Baló type. Neuropatol Pol 15: 491-500.
15. Pohl D, Rostasy K, Krone B, Hanefeld F (2005) Baló's concentric sclerosis associated with primary human herpesvirus 6 infection. J Neurol Neurosurg Psychiatry 76: 1723-1725.
16. Moore GRW, Neumann PE, Suzuki K, Lijtmaer HN, Traugott U, et al. (1985) Baló's concentric sclerosis: new observations on lesion development. Ann Neurol 17: 604-611.
17. Moore GRW, Berry K, Oger JJF, Prout AJE, Graeb DA, et al. (2001) Baló's concentric sclerosis: surviving myelin in a patient with a relapsing remitting course. Mult Scl 7: 375-382.
18. Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, et al. (2005) Tissue preconditioning may explain concentric lesions in Baló's type of multiple sclerosis. Brain 128: 979-987.
19. Wiendl H, Weissert R, Herrlinger U, Krapf H, Kuker W (2005) Diffusion abnormality in Baló's concentric sclerosis: clues for the pathogenesis. Eur Neurol 53: 42-44.
20. Anschel DJ (2006) Reply to the paper by Wiendl et al.: Diffusion abnormality in Baló's concentric sclerosis: Clues for the pathogenesis. Eur Neurol 55: 111-112.
21. Genain CP, Hauser SL (1997) Creation of a model for multiple sclerosis in Callithrix jacchus marmosets. J Mol Med 75: 187-197.
22. Michalak S (2004) Concentric patterns in the brain: a thermodynamic aspect of disease. Studia Philosophica Tartu IV(40): 139-155.
23. Ostwald W (1897) Lehrbuch der allgemeinen Chemie. Leipzig: Engelman.
24. Henisch HK (1986) Crystals in gels and Liesegang rings. Cambridge: Cambridge University Press. pp. 137-152.
25. Droz M (2000) Recent theoretical developments on the formation of Liesegang patterns. J Stat Phys 101: 509-519.
26. Krug HJ, Brandstadter H (1999) Morphological characters of Liesegang rings and their simulations. J Phys Chem 103: 7811-7820.
27. Hatschek E (1925) Der Einfluss des Lichtes auf Bleichromat-Schichtungen. Kolloid Z 37: 297-298.
28. Zeman W (1949) Konzentrische Sklerose. Arch Psychiatr Nervenkr 181: 187-197.
29. Itoyama Y, Tateishi J, Kuroiwa Y (1984) Atypical multiple sclerosis with concentric or lamellar demyelination lesions: two Japanese patients studied post-mortem. Ann Neurol 17: 481-487.
30. Gurdon JB, Harger P, Mitchell A, Lemaire P (1994) Activin signalling and response to a morphogen gradient. Nature 371: 487-492.
31. Stringini M, Cohen SM (2000) Wingless gradient formation in the Drosophila wing. Curr Biol 10: 293-300.
32. Nicholson C, Sykova E (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci 21: 207-215.
33. Venzl G, Ross J (1982) Nucleation and colloidal growth in concentration gradients (Liesegang rings). J Chem Phys 77: 1302-1307.
34. Krug HJ, Brandstädter H, Jacob KH (1996) Morphological instabilities in pattern formation by precipitation and crystallization processes. Geol Rundsch 85: 19-28.
35. Nimmerjahn A, Kirchhoff F, Helmchen F (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308: 1314-1318.
36. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, et al. (1999) A quantitative analysis of oligodendrocytes in multiple sclerosis lesions - a studi of 113 cases. Brain 122: 2279-2295.
37. Brosnan CF, Raine CS (1996) Mechanisms of immune injury in multiple sclerosis. Brain Pathol 6: 243-257.
38. Patlak CS (1953) Random walk with persistence and external bias. Bull Math Biophys 15: 311-338.
39. Keller EF, Segel LA (1971) Model for chemotaxis. J Theor Biol 30: 225-234.
40. Nanjundiah V (1973) Chemotaxis, signal relaying and aggregation morphology. J Theor Biol 42: 63-105.
41. Jäger W, Luckhaus S (1992) On explosions of solutions to a system of partial differential equations modelling chemotaxis. Trans Amer Math Soc 329: 819-824.
42. Nagai T (1995) Blow-up of radially symmetric solutions to a chemotaxis system. Adv Math Appl Sc 5: 581-601.
43. Gajewski H, Zacharias K (1998) Global behavior of a reaction-diffusion system modelling chemotaxis. Math Nachr 195: 77-114.
44. 2. C.R. Math Acad Sci Paris 339: 611-616.
45. Calvez V, Carrillo JA (2006) Volume effects in the Keller-Segel model: energy estimates preventing blow-up. J Math Pures Appl 86: 2-175.
46. Painter KJ, Hillen T (2002) Volume-filling and quorum-sensing in models for chemosensitive movement. Can Appl Math Q 10: 501-543.
47. Dolak Y, Schmeiser C (2005) The Keller-Segel model with logistic sensitivity function and small diffusivity. SIAM J Appl Math 66: 286-308.